Literature DB >> 24333532

Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.

Kerstin Felgentreff1, Matthias Siepe2, Stefan Kotthoff3, Yskert von Kodolitsch4, Kristina Schachtrup5, Luigi D Notarangelo6, Jolan E Walter7, Stephan Ehl8.   

Abstract

Loeys-Dietz syndrome (LDS) is a connective tissue disorder caused by monoallelic mutations in TGFBR1 and TGFBR2, which encode for subunits of the transforming growth factor beta (TGFβ) receptor. Affected patients are identified by vascular aneurysms with tortuosity and distinct morphological presentations similar to Marfan syndrome; however, an additional predisposition towards asthma and allergy has recently been found. We describe two patients with a novel missense mutation in TGFBR1 presenting with highly elevated levels of IgE and severe eczema similar to autosomal-dominant Hyper-IgE syndrome (HIES). Mild allergic manifestations with normal up to moderately increased IgE were observed in 3 out of 6 additional LDS patients. A comparison of this cohort with 4 HIES patients illustrates the significant overlap of both syndromes including eczema and elevated IgE as well as skeletal and connective tissue manifestations.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; EBV; EDS; Eczema; Ehlers–Danlos syndrome; Epstein–Barr virus; HIES; Hyper-IgE; Hyper-IgE syndrome; LDS; Loeys–Dietz syndrome; MFS; Marfan syndrome; T(reg); TAAD; TGF-beta; TGFBR; TGFβ; Transforming growth factor beta receptor; regulatory T cells; thoracic aortic aneurysm and dissections; transforming growth factor beta

Mesh:

Substances:

Year:  2013        PMID: 24333532     DOI: 10.1016/j.clim.2013.11.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Geetha Rao; Tanwir Habib; Danielle T Avery; Alain Lefèvre-Utile; Marie-Olivia Chandesris; Aziz Belkadi; Maya Chrabieh; Hanan Alwaseem; Virginie Grandin; Françoise Sarrot-Reynauld; Agathe Sénéchal; Olivier Lortholary; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Capucine Picard; Anne Puel; Vivien Béziat; Qian Zhang; Laurent Abel; Henrik Molina; Nico Marr; Stuart G Tangye; Jean-Laurent Casanova; Bertrand Boisson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

Review 2.  Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice.

Authors:  Aline Azabdaftari; Kelsey D J Jones; Jochen Kammermeier; Holm H Uhlig
Journal:  Hum Genet       Date:  2022-06-28       Impact factor: 4.132

Review 3.  Genetics of allergy and allergic sensitization: common variants, rare mutations.

Authors:  Klaus Bønnelykke; Rachel Sparks; Johannes Waage; Joshua D Milner
Journal:  Curr Opin Immunol       Date:  2015-09-18       Impact factor: 7.486

Review 4.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

5.  Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene.

Authors:  Karin E Lundin; Abdulrahman Hamasy; Paul Hoff Backe; Lotte N Moens; Elin Falk-Sörqvist; Katja B Elgstøen; Lars Mørkrid; Magnar Bjørås; Carl Granert; Anna-Carin Norlin; Mats Nilsson; Birger Christensson; Stephan Stenmark; C I Edvard Smith
Journal:  Clin Immunol       Date:  2015-10-19       Impact factor: 3.969

6.  A Cohort Study Comparing Women with Autism Spectrum Disorder with and without Generalized Joint Hypermobility.

Authors:  Emily L Casanova; Julia L Sharp; Stephen M Edelson; Desmond P Kelly; Manuel F Casanova
Journal:  Behav Sci (Basel)       Date:  2018-03-17

7.  Pathogenic effect of a TGFBR1 mutation in a family with Loeys-Dietz syndrome.

Authors:  Luc Cozijnsen; Astrid S Plomp; Jan G Post; Gerard Pals; Natalija Bogunovic; Kak K Yeung; Hans W M Niessen; Marie-José T H Goumans; Daniela Q C M Barge-Schaapveld; Dimitra Micha
Journal:  Mol Genet Genomic Med       Date:  2019-09-01       Impact factor: 2.183

8.  Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Peng Zhang; Franck Rapaport; Qian Zhang; Anne Puel; Vivien Béziat; Jean-Laurent Casanova; Bertrand Boisson; Takaki Asano; András N Spaan; Juan Li; Wei-Te Lei; Simon J Pelham; David Hum; Maya Chrabieh; Ji Eun Han; Antoine Guérin; Joseph Mackie; Sudhir Gupta; Biman Saikia; Jamila E I Baghdadi; Ilham Fadil; Aziz Bousfiha; Tanwir Habib; Nico Marr; Luckshman Ganeshanandan; Jane Peake; Luke Droney; Andrew Williams; Fatih Celmeli; Nevin Hatipoglu; Tayfun Ozcelik; Capucine Picard; Laurent Abel; Stuart G Tangye; Stéphanie Boisson-Dupuis
Journal:  J Exp Med       Date:  2021-06-17       Impact factor: 14.307

9.  Early-onset osteoarthritis, Charcot-Marie-Tooth like neuropathy, autoimmune features, multiple arterial aneurysms and dissections: an unrecognized and life threatening condition.

Authors:  Mélodie Aubart; Delphine Gobert; Fleur Aubart-Cohen; Delphine Detaint; Nadine Hanna; Hyacintha d'Indya; Janine-Sophie Lequintrec; Philippe Renard; Anne-Marie Vigneron; Philippe Dieudé; Jean-Pierre Laissy; Pierre Koch; Christine Muti; Joelle Roume; Veronica Cusin; Bernard Grandchamp; Laurent Gouya; Eric LeGuern; Thomas Papo; Catherine Boileau; Guillaume Jondeau
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

10.  Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function.

Authors:  Tala Shahin; Dominik Aschenbrenner; Deniz Cagdas; Sevgi Köstel Bal; Cecilia Domínguez Conde; Wojciech Garncarz; David Medgyesi; Tobias Schwerd; Betül Karaatmaca; Pınar Gur Cetinkaya; Saliha Esenboga; Stephen R F Twigg; Andrew Cant; Andrew O M Wilkie; Ilhan Tezcan; Holm H Uhlig; Kaan Boztug
Journal:  Haematologica       Date:  2018-10-11       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.